Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/EP2012/056069, filed Apr 3, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,085,631 | Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus In force · High confidence | Evaxion Biotech A/S | In force | High confidence | ||
| US 9,534,022 | Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus In force · High confidence | Evaxion Biotech A/S | In force | High confidence | ||
| US 10,034,928 | Proteins and Nucleic Acids Useful in Vaccines Targeting Staphylococcus Aureus In force · High confidence | Evaxion Biotech A/S | In force | High confidence | ||
| US 10,675,340 | Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus In force · High confidence | Evaxion Biotech A/S | In force | High confidence | ||
| US 11,052,145 | Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus In force · High confidence | Evaxion Biotech A/S | In force | High confidence | ||
| Application 17/351,032 | Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus Abandoned Abandoned Feb 12, 2026 | Evaxion Biotech A/S | Abandoned | Abandoned Feb 12, 2026 |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Evaxion Biotech A/S.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.